Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a …

…, NJK Breitborde, H Brenner, ADM Briggs, PM Brooks… - The lancet, 2015 - thelancet.com
Background Up-to-date evidence about levels and trends in disease and injury incidence,
prevalence, and years lived with disability (YLDs) is an essential input into global, regional, …

Nonsteroidal antiinflammatory drugs—differences and similarities

PM Brooks, RO Day - New England Journal of Medicine, 1991 - Mass Medical Soc
John A. Oates, MD, Editor Alastair JJ Wood, MD, Associate Editor THE nonsteroidal
antiinflammatory drugs (NSAIDs) are very commonly prescribed. This fact reflects the high …

The burden of musculoskeletal disease—a global perspective

PM Brooks - Clinical rheumatology, 2006 - Springer
Musculoskeletal diseases are one of the major causes of disability around the world and have
been a significant reason for the development of the Bone and Joint Decade. Rheumatoid …

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013 …

…, NJK Breitborde, H Brenner, AD Briggs, PM Brooks… - The Lancet, 2015 - thelancet.com
Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together
all available epidemiological data using a coherent measurement framework, standardised …

[HTML][HTML] A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery

…, KL Tribe, BG Courtenay, PM Brooks… - Osteoarthritis and …, 2001 - Elsevier
Objective The aims of this study were to assess changes in physical function and quality of
life with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and …

Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications

PM Brooks - Current opinion in rheumatology, 2002 - journals.lww.com
Osteoarthritis is a major cause of disability in both the developed and developing world. With
the population aging, the prevalence of osteoarthritis is increasing and its consequences …

[PDF][PDF] Simulation in clinical teaching and learning

JM Weller, D Nestel, SD Marshall, PM Brooks… - Medical Journal of …, 2012 - mja.com.au
2 MJA 196 (9)· 21 May 2012 back to students from the patient perspective. 6 Specifically
trained simulated patients, known as clinical teaching associates, are used in some Australian …

Does colchicine work? The results of the first controlled study in acute gout

…, TP Gordon, M McCredle, PM Brooks… - Australian and New …, 1987 - Wiley Online Library
We have performed the first controlled study of colchicine in acute gout, to determine its
efficacy and toxicity, and to define the natural history of acute gout. Two‐thirds of colchicine‐…

Clinical pharmacokinetics of the salicylates

CJ Needs, PM Brooks - Clinical pharmacokinetics, 1985 - Springer
The use of salicylates in rheumatic diseases has been established for over 100 years. The
more recent recognition of their modification of platelet and endothelial cell function has lead …

Outcomes after hip or knee replacement surgery for osteoarthritis

…, KL Tribe, BG Courtenay, PM Brooks - The Medical Journal of …, 1999 - mja.com.au
… Lyn M March, Marita J Cross, Helen Lapsley, Katherine L Tribe, Brett G Courtenay and
Peter M Brooks … Katherine L Tribe, Clarissa JM Bachmeier, Brett G Courtenay and Peter …